Cardiac Prosthetic Devices Market, By Product Type (Heart Valves (Mechanical Heart Valves, Tissue Heart Valves(Tissue Heart Valves and Stentless Tissue Valves) and Transcatheter Heart Valves), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others (Academic & Research Institutes and Others)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jun 2023

Code : CMI3862

Pages :155

Formats :

Excel and PDF

Industry : Medical Devices

Market News

Global Cardiac Prosthetics Devices Market: Key Developments

On February 9, 2023, Royal Philips, a global leader in health technology, announced that it had entered into a long-term strategic partnership with TriHealth, a leading Cincinnati-based integrated healthcare delivery system, to adopt Philips’ integrated portfolio of cardiology solutions for its new TriHealth Heart & Vascular Institute on the campus of Bethesda North Hospital and the Harold and Eugenia Thomas Comprehensive Care Center.

In August 2021, Millar, Inc., a medical device company, and Schwarzer Cardiotek, a medical technology manufacturer, announced that they had entered into a strategic partnership to promote the direct connection between the Millar Mikro-Cath and the EP-Tracer recording system to improve the efficient implantation and optimal placement of pacemakers.

In January 2021, Boston Scientific, a medical device company, announced that it had entered into a definitive agreement to acquire Preventice Solutions, Inc., a privately-held company that offers a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors – including short and long-term Holter monitors – to cardiac event monitors and mobile cardiac telemetry.

In March 2020, SynCardia Systems, LLC, a privately-held manufacturer of Total Artificial Heart, received the U.S. Food and Drug Administration (FDA) approval for its 50cc temporary Total Artificial Heart (TAH) System as a bridge to heart transplant.